A biomarker used to detect a rare neurodegenerative disorder of cholesterol metabolism, Niemann-Pick disease type C1 (NPC1), may also be useful for diagnosing another class of rare diseases known as congenital disorders of glycosylation (CDG), suggests a study by researchers at the National Institutes of Health.
News
NICHD issues News Releases and Media Advisories to the news media. Spotlight and Research Feature articles explain NICHD research findings and public health issues to the general public. An Item of Interest is a short announcement of relevant information, such as a notable staff change.
Science Update: Uterine fibroids may slightly increase fetal size but not enough to interfere with birth process, NIH study suggests
Uterine fibroids during pregnancy do not appear to result in undersized newborns, suggests a study by researchers at the National Institutes of Health. The finding allays concerns from previous studies that fibroids might result in smaller-than-normal infants. In fact, the study found that infants born to mothers with fibroids had slightly larger head, arm and thigh circumferences, though not to the extent that they would interfere with birth. The researchers also confirmed prior results suggesting a link between fibroids and increased risk for preterm birth.
Director's Corner: Understanding How Digital Media Affects Child Development
In this increasingly digital world, we must strive to better understand how technology and media affect development, health outcomes, and interpersonal relationships from infancy through adolescence. NICHD has a longstanding commitment to research on these topics.
Director's Corner: Reflecting on NICHD’s 60th Anniversary Year
Research conducted at NICHD and at NICHD-funded institutions continues to bring us closer to fulfilling our vision of ensuring healthy pregnancies, healthy children, and healthy and optimal lives.
Director's Corner: The Promise of Precision Nutrition Research
What defines eating for health? Clearly, there is no one-size-fits-all healthy diet. The emerging field of precision nutrition aims to deliver personalized dietary recommendations to optimize health and quality of life based on an individual’s genetics, gut microbes, and other biological, lifestyle, environmental, and social factors.
Release: Prenatal steroid treatment may improve survival, reduce complications for extremely preterm infants
Steroid treatment before birth appears to improve survival and reduce complications among extremely preterm infants, according to a study funded by the National Institutes of Health. Antenatal steroid therapy, given to women at risk of preterm delivery, causes the fetal lungs to mature and has been shown to improve survival and reduce complications among infants born from 24 to 34 weeks of pregnancy. However, previous studies of the treatment for infants born between the 22nd and 23rd week—those at greatest risk for death and disability—were inconclusive.
Spotlight: Advancing neuroscience research for children around the world
Eight years ago, NIH announced a collaboration with the Bill & Melinda Gates Foundation to develop solutions for a variety of global health challenges. Learn how NICHD research is supporting this goal.
Release: Umbilical cord milking may improve health in non-vigorous term and near-term infants
A treatment to move blood from the umbilical cord into an infant’s body may improve the overall health of newborns classified as non-vigorous—limp, pale and with minimal breathing, suggests a study funded by the National Institutes of Health. The procedure, known as umbilical cord milking, involves gently squeezing the cord between the thumb and forefinger and slowly pushing the blood into the abdomen.
Item of Interest: NIH-funded research leads to pediatric labeling updates for diazepam and clindamycin
Drug labels for diazepam and clindamycin now include better information for healthcare
providers on recommended usage and dosage in pediatric populations.
Director's Corner: Advancing Infant Nutrition Research
The recent shortage of infant formula underscores its importance for the health of children in the United States, making this an opportune time for Dr. Bianchi to reflect on NICHD’s work to advance infant nutrition research.
Science Update: Hormone prevents obesity in offspring of pregnant mice with obesity, according to NIH-funded study
Giving the hormone adiponectin to pregnant mice with obesity prevented later life obesity and related health conditions in their offspring, according to a study funded by the National Institutes of Health. The findings suggest that adiponectin, a hormone produced by fat cells, could play a role in reducing the lifelong obesity risk of children born to mothers with obesity during pregnancy.
Spotlight: Small Business Success Stories
NICHD-funded small business programs have led to innovations for patients, healthcare providers, researchers, and more. Learn about these success stories.
Science Update: Scientists develop noninvasive method to predict congenital CMV infection
Researchers have developed a calculator to estimate the risk that cytomegalovirus (CMV) will pass to a fetus during pregnancy. By offering a noninvasive way to predict the chance of congenital CMV based on individual characteristics, this tool may help healthcare providers counsel pregnant people with CMV.
Director's Corner: The Power of Networks
Clinical research networks bring together scientists, clinicians, and community stakeholders to identify important clinical questions and design and conduct high-quality studies to answer them. Scientific evidence generated by such studies can impact clinical care, as several recent findings from NICHD’s networks demonstrate.
Science Update: No differences in neurological impairment by second year for infants treated with dextrose for low blood sugar, NIH-funded study finds
Treating newborns at risk for hypoglycemia (low blood sugar) with a preventive oral dose of the sugar dextrose does not appear to increase their overall risk for neurological or sensory impairment at age 2, suggests a study funded by the National Institutes of Health. However, compared to a similar group of at-risk infants treated with a placebo, children treated as infants had a slightly higher risk of motor delay and slightly lower scores on a test of cognitive, language, and motor skills. The authors concluded that the study may not have included enough participants to detect an increased risk for adverse effects. They urged caution in treating infants at risk for hypoglycemia preventively with dextrose gel and called for future evaluations of the study participants later in childhood.
Media Advisory: Hydrocortisone does not prevent lung complication in extremely preterm infants
Hydrocortisone is no more effective than placebo at preventing damage that can result from oxygen and ventilator therapy necessary to keep preterm infants alive, according to research funded by the National Institutes of Health. The study of a potential treatment for the condition, known as bronchopulmonary dysplasia, appears in the New England Journal of Medicine.
Science Update: Juice consumption before six months linked to childhood overweight and obesity, NIH study suggests
Children who were first given juice before they were six months old were more likely to have overweight or obesity in early and mid-childhood, compared to kids who were given juice at one year old or later, according to a study by researchers at the National Institutes of Health. The finding provides additional support for a theory that giving young children sweet foods or drinks may foster a preference for sweet tastes that can lead to weight gain later in childhood.
Science Update: COVID-19 vaccination during pregnancy may help protect offspring from SARS-CoV-2 through age 6 months, small NIH-funded study suggests
Vaccinating women against SARS-CoV-2 in mid to late pregnancy could provide their infants at least some protection against COVID-19 through six months of age, suggests a small study funded by the National Institutes of Health. Compared to infants born to mothers who had COVID-19 during pregnancy, infants born to vaccinated mothers were much more likely to have antibodies against the virus.
Science Update: Development scores higher for infants born later in term pregnancy, NIH study suggests
On average, scores on development tests were lower for infants born earlier in the range of a term pregnancy—from 37 to 41 weeks—than for those born later in the range, suggests a study by researchers at the National Institutes of Health. The slight difference in scores, first apparent at eight months, persisted through age seven. The findings may have implications for current practice guidelines recommending induction of labor for non-medical reasons at the 39th week of pregnancy.
Media Advisory: SARS-CoV-2 may cause fetal inflammation even in the absence of placental infection
Small NIH study contributes to understanding of COVID-19 during pregnancy.